Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Convertible Debt: 2023-2024

Historic Convertible Debt for Abivax (ABVX) over the last 2 years, with Dec 2024 value amounting to $25.3 million.

  • Abivax's Convertible Debt rose 681.50% to $27.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $27.4 million, marking a year-over-year increase of 681.50%. This contributed to the annual value of $25.3 million for FY2024, which is 21.02% down from last year.
  • Per Abivax's latest filing, its Convertible Debt stood at $25.3 million for FY2024, which was down 21.02% from $32.0 million recorded in FY2023.
  • Abivax's Convertible Debt's 5-year high stood at $32.0 million during FY2023, with a 5-year trough of $25.3 million in FY2024.
  • For the 2-year period, Abivax's Convertible Debt averaged around $28.7 million, with its median value being $28.7 million (2023).
  • Data for Abivax's Convertible Debt shows a maximum YoY decreased of 21.02% (in 2024) over the last 5 years.
  • Abivax's Convertible Debt (Yearly) stood at $32.0 million in 2023, then fell by 21.02% to $25.3 million in 2024.